Mark Bonnen

4.6k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Mark Bonnen is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Mark Bonnen has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 10 papers in Surgery. Recurrent topics in Mark Bonnen's work include Advanced Radiotherapy Techniques (13 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Bonnen is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Bonnen collaborates with scholars based in United States, Brazil and China. Mark Bonnen's co-authors include Radhe Mohan, Barbara Pro, Dima Suki, Jaffer A. Ajani, Bouthaina S. Dabaja, J OˈDaniel, Lei Dong, Deborah A. Kuban, Rex Cheung and Adam S. Garden and has published in prestigious journals such as Cancer, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mark Bonnen

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy

2005 473 citations Radhe Mohan, Adam S. Garden et al. profile →

Peers

Countries citing papers authored by Mark Bonnen

Since Specialization

Citations

This map shows the geographic impact of Mark Bonnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bonnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bonnen more than expected).

Fields of papers citing papers by Mark Bonnen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bonnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bonnen. The network helps show where Mark Bonnen may publish in the future.

Co-authorship network of co-authors of Mark Bonnen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bonnen. A scholar is included among the top collaborators of Mark Bonnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bonnen. Mark Bonnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast Radiation Therapy Survivorship and Cancer Support Groups: an Opportunity for Community Engagement and Education Through the Addressing Breast Cancer Dermatologic Side Effects (ABCDEs) Program 2024 ·Journal of Cancer Education ·(unknown), (unknown), Clark L. Anderson, Joshua Asper, (unknown), Mark Bonnen, (unknown), (unknown)	0
2	Dosimetric characterization of a new surface‐conforming electron MLC prototype 2023 ·Journal of Applied Clinical Medical Physics ·(unknown), (unknown), Thomas R. Martin, Daniel Saenz, Pamela Myers, Karl Rasmussen, S Stathakis, Mark Bonnen, N Papanikolaou, Neil Kirby	2
3	Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis 2022 ·Scientific Reports ·Afshin Ebrahimpour, Manisha Ahir, Min Wang, Anil G. Jegga, Mark Bonnen, N. Tony Eissa, Sydney B. Montesi, Ganesh Raghu, Yohannes T. Ghebre	9
4	Proton pump inhibitors and sensitization of cancer cells to radiation therapy 2022 ·Frontiers in Oncology ·(unknown), Mark Bonnen, Yohannes T. Ghebre	5
5	Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway 2021 ·Journal of Inflammation ·Afshin Ebrahimpour, Min Wang, Li Li, Anil G. Jegga, Mark Bonnen, N. Tony Eissa, Ganesh Raghu, Soma Jyothula, Farrah Kheradmand, Nicola A. Hanania, Iván O. Rosas, Yohannes T. Ghebre	13
6	Outcome Of Bladder Preservation with Combined Modality Treatment In the Modern Era Of Radiation Therapy For Muscle Invasive Bladder Cancer: A Single Tertiary Cancer Center Experience 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Dharam Kaushik, Klaus Rasmussen, (unknown), Nickolas Papanikolaou, Mark Bonnen, Zhiyi Shi	0
7	Emotional disclosure and cognitive processing in couples coping with head and neck cancer 2019 ·Journal of Behavioral Medicine ·Jafar Bakhshaie, Mark Bonnen, Joshua Asper, Vlad C. Sandulache, Hoda Badr	7
8	Dyadic Coping in Patients Undergoing Radiotherapy for Head and Neck Cancer and Their Spouses 2018 ·Frontiers in Psychology ·Hoda Badr, Krista Herbert, Mark Bonnen, Joshua Asper, Timothy Wagner	34
9	Inversely and adaptively planned interstitial brachytherapy: A single implant approach 2018 ·Gynecologic Oncology ·Alexander N. Hanania, Pamela Myers, (unknown), (unknown), Zhiqian Yu, (unknown), (unknown), Mark Bonnen, (unknown), T.R. Hall, Matthew L. Anderson, Michelle Ludwig	6
10	Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Afshin Ebrahimpour, (unknown), Mark Bonnen, N. Tony Eissa, Ganesh Raghu, Yohannes T. Ghebre	28
11	Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System 2017 ·International Journal of Gynecological Cancer ·(unknown), (unknown), (unknown), Joshua Asper, Mark Bonnen, Michelle Ludwig	5
12	Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model 2017 ·Frontiers in Pharmacology ·Christina Nelson, (unknown), Kang Ko, Andrew G. Sikora, Mark Bonnen, Perenlei Enkhbaatar, Yohannes T. Ghebre	25
13	Pre-treatment peer-review: enhancing value through increased efficiency and effectiveness of radiation oncology peer review 2017 ·Journal of Radiation Oncology ·(unknown), Joshua Asper, Mark Bonnen, Henry Mok, Timothy Wagner, Michelle Ludwig, L.Steven Carpenter, (unknown)	3
14	Compliance to Radiation Therapy for Head and Neck Cancer in a Safety-Net Health System 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Michelle Ludwig, (unknown), (unknown), Mark Bonnen	1
15	The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is “young”? 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Julia Oh, Mark Bonnen, Elesyia D. Outlaw, Naomi R. Schechter, George H. Perkins, Eric A. Strom, Gildy V. Babiera, Mary Jane Oswald, Pamela K. Allen, Howard D. Thames, Thomas A. Buchholz	44
16	Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer 2005 ·Radiotherapy and Oncology ·Anurag Chandra, Thomas Guerrero, (unknown), Susan L. Tucker, Zhongxing Liao, Xiaochun Wang, Hasan Murshed, Mark Bonnen, Amit Garg, Craig Stevens, Joe Y. Chang, (unknown), Radhe Mohan, James D. Cox, Ritsuko Komaki	139
17	Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck 2004 ·Cancer ·Mark Bonnen, Matthew T. Ballo, Jeffrey N. Myers, Adam S. Garden, Eduardo M. Diaz, Jeffrey E. Gershenwald, William H. Morrison, Jeffrey E. Lee, Mary Jane Oswald, Merrick I. Ross, K. Kian Ang	46
18	Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Mark Bonnen, Christopher H. Crane, Jean‐Nicolas Vauthey, John M. Skibber, Marc E. Delclos, Miguel A. Rodrı́guez-Bigas, Paulo M. Hoff, Edward H. Lin, Cathy Eng, Adrian Wong, Nora A. Janjan, Barry W. Feig	140
19	Adjuvant irradiation for cervical lymph node metastases from melanoma 2003 ·Cancer ·Matthew T. Ballo, Mark Bonnen, Adam S. Garden, Jeffrey N. Myers, Jeffrey E. Gershenwald, Gunar K. Zagars, Naomi R. Schechter, William H. Morrison, Merrick I. Ross, K. Kian Ang	75
20	Long term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients 2001 ·International Journal of Radiation OncologyBiologyPhysics ·Mark Bonnen, (unknown), Barry W. Feig, J. M. Skibber, Matthew T. Ballo, Marc E. Delclos, (unknown), (unknown), T. Phan, Nora A. Janjan	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact